Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Decade of Development for SMSI: Will it lead to Improved Accuracy in CGM?

This article was originally published in Start Up

Executive Summary

The mission of ten-year old company Sensors for Medicine & Science is to develop a sensor that would obviate the need for patients with diabetes to extract blood or fluid samples for testing. Implanted under the skin, the SMSI sensor is continuously immersed in interstitial fluid containing glucose and provides frequent glucose readings. It thus has the potential to become the cornerstone of a new continuous glucose monitoring (CGM) system, one that works very differently than the early-generation systems on the market today. Part of a group of articles that includes: "Where are They Now? Checking in on Three Glucose Monitoring Companies," "Pelikan Swoops in on the Big Four" and "GlucoLight: Making Non-Invasive Glucose Monitoring Real."

Related Content


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts